Quick Answer
Nurix Therapeutics, Inc. reported Net Income of -$264.46 million for fiscal year 2025.
Nurix Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$264.46M | -36.6% |
| 2024 | -$193.57M | -34.5% |
| 2023 | -$143.95M | +20.2% |
| 2022 | -$180.36M | -53.9% |
| 2021 | -$117.19M | -171.0% |
| 2020 | -$43.24M | -99.3% |
| 2019 | -$21.70M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| August 31, 2025 | -$86.42M | -76.5% | -98.8% |
| May 31, 2025 | -$43.46M | +2.4% | +22.9% |
| February 28, 2025 | -$56.35M | -35.7% | -15.1% |
| August 31, 2024 | -$48.96M | -32.4% | -9.9% |
| May 31, 2024 | -$44.55M | -83.5% | -7.3% |
| February 29, 2024 | -$41.52M | -1.9% | -12.3% |
| August 31, 2023 | -$36.98M | +19.1% | -52.3% |
| May 31, 2023 | -$24.28M | +46.5% | +40.4% |
- Nurix Therapeutics, Inc. showed a decrease of -36.6% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Nurix Therapeutics, Inc.’s net income has declined by 1118.8% (from -$21.70 million to -$264.46 million).
- The most recent figure is from Nurix Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 28, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: